Please login to the form below
Big pharma limits deliveries to Greece
A number of big pharma, including Roche and Sanofi, have started limiting drug deliveries to some hospitals in Greece because of unpaid bills, according to the UK newspaper the Times
A number of big pharma, including Roche and Sanofi, have started limiting drug deliveries to some hospitals in Greece because of unpaid bills, according to the UK newspaper the Times.
The newspaper reported that Roche has halted deliveries to public hospitals that have not paid their bills since September. However, the Swiss company will continue to supply medicines it considers to be life-saving, the Times said.
GlaxoSmithKline told PMLiVE that it is in talks with the Greek government, but will not halt deliveries.
Nycomed may also suspend deliveries if the situation worsens, according to the Times.
Nycomed, Roche and Sanofi were unavailable to comment at the time of writing.
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
- Editorial Team Leader, Medical Communications, Oxford
-
Competitive Salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Graduate Business Analyst, Healthcare Communications – Pharma/ S...
-
Highly competitive salary
-
Head of Copy
-
£ competitive
- AstraZeneca's Enhertu receives FDA grant for priority review
- Why pharma must get smart in its approach to customer engagement
- AstraZeneca’s Imfinzi and tremelimumab show unprecedented survival rate in liver cancer patients
- Pfizer’s Cibinqo granted FDA approval for adults with moderate-to-severe atopic dermatitis
- GSK appoint Tony Wood as chief scientific officer
- Anthem PR appoints new managing director Rebecca Fergusson
- PM announces plans to lift England’s COVID-19 restrictions
- Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment
- Developing Innovative Digital Strategies to Engage Patients
- GSK appoint Tony Wood as chief scientific officer
- Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results
- Cervical Cancer Prevention Month
PMHub
Bedrock Healthcare Communications
Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...
Latest intelligence
- Cervical Cancer Prevention Month
- In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...
- 6 critical success factors for flawless execution of a rapid first commercial launch
- Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline....
- Hybrid working: Insights and tips for success
- Porterhouse Medical has thrived by embracing a hybrid approach to work. Our article looks at hybrid working and provides some tips for success...
